VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
CHANGCHUN HIGH-TECH: Leuprorelin Mesilate Injection (6M) Marketing Application Accepted by NMPA
CHANGCHUN HIGH-TECH: Leuprorelin Mesilate Injection (6M) Marketing Application Accepted by NMPA
May 29, 2026 17:45 CST Updated 18:11
Share:
CHANGCHUN HIGH-TECH
Pharmaceutical R&D Developer
GenSci
Gene Engineering Pharmaceutical and Growth Hormone Producer